Navigation Links
Osteotech Posts First Quarter Earnings Per Share of $.05 on Revenue Growth of 10%
Date:5/1/2008

EATONTOWN, N.J., May 1 /PRNewswire-FirstCall/ -- Osteotech, Inc. (Nasdaq: OSTE), a leader in the emerging field of biological products for regenerative healing, announced today that revenue for the first quarter of 2008 increased 10% to $27.6 million from $25.2 million for the first quarter of 2007. Revenue from the Company's primary product lines, included in the DBM and Hybrid/Synthetic segments, was $17.6 million for the three months ended March 31, 2008, an increase of 12% over the prior year period. Revenue from our other product lines was $10.0 million and $9.5 million in the first quarter of 2008 and 2007, respectively.

Diluted earnings per share for the quarter ended March 31, 2008 was $.05 on net income of $.8 million compared to a net loss of $.6 million, or $.04 diluted loss per share, for the first quarter of 2007. The net loss in the first quarter of 2007 included the costs associated with the settlement of certain litigation and related legal fees of $1.1 million.

Gross margin improved to 52% in the first quarter compared to 49% in the first quarter of the prior year. Operating expenses increased 5% for the three months ended March 31, 2008 compared to the same period in 2007 due primarily to increased spending in research and development activities.

Sam Owusu-Akyaw, Osteotech's President and Chief Executive Officer, stated, "We continue to be pleased with the execution of our strategic initiatives. During the first quarter, we have continued to expand our product pipeline, penetrate the foot and ankle market with our Plexur P(TM) product and improve the effectiveness of our sales force. In the past two months, we have received FDA clearance for our Plexur P(TM) product for use in the spine and the Plexu
'/>"/>

SOURCE Osteotech, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Osteotech to Present at Roth Capital Partners 2007 New York Investor Conference
2. Osteotech to Present at Sidoti Conference in San Francisco
3. Osteotech Announces Fourth Quarter and Full Year Earnings Release and Conference Call Schedule
4. Osteotech Reports 2007 Full Year and Fourth Quarter Financial Results; Full Year Revenue of $104.3 Million Exceeds $100 Million Milestone; Diluted Earnings Per Share Was $.15 in 2007
5. Osteotech to Present at the Canaccord Adams Small-Cap Orthopedics Conference in San Francisco
6. Osteotech Receives FDA Clearance for Plexur M(TM) Biocomposite
7. Osteotech to Present at the Sidoti Conference in New York
8. U.S. Patent Office Confirms Validity of Osteotechs U.S. Patent No. 5,676,146
9. Osteotech Announces First Quarter Earnings Release and Conference Call Schedule
10. Osteotech Renews Tissue Recovery Agreement with the Euro Atlantic Transplant Alliance
11. Osteotechs Plexur P(TM) Receives FDA Clearance as Bone Void Filler and Bone Graft Extender in Spine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... to the International Atomic Energy Agency (IAEA) the ... acquiring sufficient quantities of plutonium or highly enriched ... device. The IAEA also notes that most cases ... which can be challenging to detect with most ... appearing this week in the Journal of ...
(Date:7/10/2014)... published today in the journal PNAS (Proceedings of ... time of day and sleep deprivation have a significant ... when looking at the best time of day to ... and for administering medicines effectively. , Researchers from the ... London, investigated the links between sleep deprivation, body clock ...
(Date:7/10/2014)... The lithium-ion batteries that power our laptops and ... on a single charge with the help of a ... material to replace the graphite traditionally used in one ... 10 times the energy storage capacity of graphite. A ... electrode was published today in Nature Communications . ...
(Date:7/10/2014)... A recent study by researchers at the University ... the physical mechanisms governing the interplay of spin ... fundamental limits of ultrafast spintronic devices for data ... a charge as well as spin-angular momentum. In ... so there is no spin current," explained David ...
Breaking Biology Technology:Sensitive detection method may help impede illicit nuclear trafficking 2Time of day crucial to accurately test for diseases, new research finds 2Silicon sponge improves lithium-ion battery performance 2Silicon sponge improves lithium-ion battery performance 3University of Illinois study advances limits for ultrafast nano-devices 2
... , , ... luminescence of lanthanide ions has long been a challenge for the spectroscopist. Methods to counter ... Protective ligands to reduce vibrational quenching effects by XH ... Deuterated solvents (also to reduce quenching effects of XH). , ...
... , , , The optical properties of quantum dots (QDs) have potential applications, ... memory devices, and ... herein to possess a nonlinear change ... correlated to size and composition, as monitored by the versatile, ...
... , ... The chemistry, spectroscopy, and reactivity of singlet oxygen, 1 O 2 ... mechanisms of photo-oxygenation. 1 Recently, research has been directed towards understanding ... photodynamic destruction of cells in the presence of a dye, oxygen, and ...
Cached Biology Technology:Time gated separation of lanthanide luminescence 2Photoluminescence Spectroscopy of Quantum Dots, monitored by the Spex FluoroMax 2Photoluminescence Spectroscopy of Quantum Dots, monitored by the Spex FluoroMax 3Photoluminescence Spectroscopy of Quantum Dots, monitored by the Spex FluoroMax 4Singlet Oxygen measurement 2
(Date:7/11/2014)... Sweden, have explored two different ways that allow ... to the formation of oxygen molecules in photosynthesis. ... scientific journal Nature Communications . , "The ... catalysts for water oxidation, which are key components ... storage of solar energy in fuels like hydrogen, ...
(Date:7/11/2014)... demonstrated that transplantation of mesenchymal stem cells can stimulate ... models of Alzheimer,s disease (AD) and improve tissue and ... studies are reported on the therapeutic effect of adipose-derived ... on the effect on oxidative injury and neurogenesis in ... her team, School of Life Sciences, Tsinghua University, China ...
(Date:7/11/2014)... 1 can inhibit voltage-gated calcium channel, decrease ... However, some scholars demonstrated that cannabinoid receptor ... and increase neurotransmitter release. Dr. Yi Zhang ... Tongji Medical College, Huazhong University of Science ... and calcium imaging in cultured trigeminal ganglion ...
Breaking Biology News(10 mins):Molecular snapshots of oxygen formation in photosynthesis 2
... Claims that tropical forests are declining cannot be backed up ... of Leeds. This major challenge to conventional thinking is ... Proceedings of the US National Academy of Sciences by Dr ... world,s leading experts on tropical deforestation. "Every few years ...
... Biotech Inc. (TSX: ONC, NASDAQ: ONCY) (Oncolytics) reported ... Richard Vile of the Mayo Clinic College of ... its work testing the antitumor efficacy and safety ... vivo. The paper, entitled Cyclophosphamide Facilitates Antitumor ...
... -- The National Academy of Sciences (NAS) and Institute ... a book designed to give the public a comprehensive ... evolution and its importance in the science classroom. ... abundance of observations and experiments over the past 150 ...
Cached Biology News:No convincing evidence for decline in tropical forests 2No convincing evidence for decline in tropical forests 3Scientific evidence supporting evolution continues to grow 2Scientific evidence supporting evolution continues to grow 3
... Recognizes VAMP-2 (Vesicle-Associated Membrane Protein ... does not share homology with ... It is expected that ... with human, Macaca multata and ...
... Vesicular Monoamine Transporter 2 (VMAT2). An antibody ... a major band at ~55 kDa in ... and not in wild type cells (2). ... molecular weight, were also detected and remain ...
Immunogen for A300-655A was a phosphorylated synthetic peptide, which represented a portion of human RNA Polymerase II (GeneID 5430) around serine 5 of the C-terminal repeat YSPTSPS....
... CLS number is a new ... match Cornings product number. If ... order under the old Sigma-Aldrich ... service for assistance. Mfr ...
Biology Products: